ReviewACS omega2025
Engineering Nanomaterials for Raman Bioimaging and Theranostics: Advances, Challenges, and Future Directions.
Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial Materials: Special Issue on Advances in Luminescent Materials.Materials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Raman imaging is rapidly advancing as a transformative platform for noninvasive, label-free molecular analysis across biomedical applications. Recent innovations in nanomaterials and photonics have enabled this technique to offer unprecedented spatial and chemical resolution. Advanced strategies such as cryogenic Raman microscopy, machine learning-enhanced hyperspectral analysis, and multimodal systems that integrate Raman spectroscopy with magnetic resonance imaging and photothermal therapy are now being developed to push the boundaries of imaging resolution and real-time analysis. This review focuses on integrating advanced Raman modalities with engineered nanostructures, particularly iron oxide-based hybrid nanoparticles, to achieve real-time, high-sensitivity imaging and targeted therapeutic delivery. Key challenges are critically addressed, including signal reproducibility, photodamage, and clinical translation. Finally, a conceptual framework is proposed linking material design, intelligent sensing, and adaptive therapeutics, positioning Raman imaging as a central component in next-generation theranostic platforms for precision healthcare.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.